Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine

Gastroenterology
Carla GiordanoValerio Carelli

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive disease clinically defined by gastrointestinal dysmotility, cachexia, ptosis, ophthalmoparesis, peripheral neuropathy, white-matter changes in brain magnetic resonance imaging, and mitochondrial abnormalities. Loss-of-function mutations in thymidine phosphorylase gene induce pathologic accumulations of thymidine and deoxyuridine that in turn cause mitochondrial DNA (mtDNA) defects (depletion, multiple deletions, and point mutations). Our study is aimed to define the molecular basis of gastrointestinal dysmotility in a case of MNGIE. By using laser capture microdissection techniques, we correlated histologic features with mtDNA abnormalities in different tissue components of the gastrointestinal wall in a MNGIE patient and ten controls. The patient's small intestine showed marked atrophy and mitochondrial proliferation of the external layer of muscularis propria. Genetic analysis revealed selective depletion of mtDNA in the small intestine compared with esophagus, stomach, and colon, and microdissection analysis revealed that mtDNA depletion was confined to the external layer of muscularis propria. Multiple deletions were detected in the uppe...Continue Reading

Citations

Feb 7, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ayman W El-Hattab, Fernando Scaglia
Jul 15, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Lara GibelliniMarcello Pinti
Jan 24, 2007·Lancet Neurology·Lionel GinsbergJan-Willem Taanman
Feb 28, 2008·Current Opinion in Gastroenterology·Michael P Jones, Jason R Bratten
Mar 23, 2017·Journal of Inherited Metabolic Disease·Carlo Viscomi, Massimo Zeviani
Nov 18, 2017·Virchows Archiv : an International Journal of Pathology·Bruna CerbelliCarla Giordano
Jul 20, 2007·Proteomics·Ferdinand von EggelingGünther Ernst
Feb 5, 2009·Journal of Internal Medicine·A Spinazzola, M Zeviani
Sep 22, 2007·Current Opinion in Neurology·Massimo Zeviani, Valerio Carelli
Apr 17, 2009·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·V ZimmerM Menges
Oct 30, 2009·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M BöttnerT Wedel
Jun 25, 2020·Proteomics·Ferdinand von Eggeling, Franziska Hoffmann
Mar 2, 2010·Médecine sciences : M/S·Emmanuelle Sarzi, Agnès Rötig
Mar 4, 2021·American Journal of Physiology. Gastrointestinal and Liver Physiology·Elisa BoschettiRoberto De Giorgio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.